Image by Freepik
Biochemical researchers at Case Western Reserve University have discovered a new role of a critical protein that causes cancer growth, a discovery that they predict could lead to more effective treatments for a variety of malignancies and other ailments.
LSD1 (lysine-specific histone demethylase 1A) is the protein in query, and it acts like a traffic cop inside human cells. It modulates gene expression and affects gene activity throughout embryonic development.
In recent years, scientists have shown that overexpression of LSD1 (creating too many proteins) can contribute to the development of cancer and heart disease.
And, more recently, some researchers have attempted to decrease cancer growth by inhibiting the catalytic activity of LSDI—the chemical reaction that promotes cell growth but also appears to contribute to its overexpression.
However, Kaixiang Cao, an assistant professor of biochemistry, is leading a team that seeks to challenge that assumption: the medical school researchers argue that they can achieve far greater success in inhibiting or preventing cancer growth in stem cells by degrading the entire LSD1 protein rather than simply short-circuiting the chemical reaction that leads to its overexpression.
“Our findings really challenge the current paradigm,” Cao said.
“We need a really precise and effective way of targeting these proteins, and our research shows that stopping that catalysis might be effective (at stopping the overexpression) 15% of the time, while our approach is closer to 80%,” Cao said. “So, if we can develop a degrader of LSD1, we can help the patient go through less therapy—even if we cannot completely cure cancer.”
Cao said he and his team were surprised LSD1 functions mainly in a catalytic-independent manner, but now that they’ve provided to the research community a “theoretical foundation that this is going to be a more effective way to treat these diseases,” they’ll begin to test further, first in cancerous tissues, then animal models and eventually human trials.
“This is the future—you add the degrader, and it will kill the protein completely,” he said. “The technique is already there because it has been done to other proteins by other researchers—but not yet to LSD1.”
For more information:
Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition, Nature Communications
more recommended stories
Air Pollution Hurts Brain Health in Just 4 HoursAir Pollution Blurs the Mind, Impairs.
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disordersUrgent treatment solutions are needed for.
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences DivisionThe High-Level Meeting on antimicrobial resistance.
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences DivisionThe installation was commissioned to mark.
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences DivisionScientists at the University of Oxford,.
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences DivisionAntimicrobial resistance (AMR) threatens the foundation.
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences DivisionThe TyVOID study, published in the Lancet, measured the.
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences DivisionThe research addresses the long-recognized poor.
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences DivisionOnly 30 prizes are awarded throughout.
Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences DivisionThe Nikon Small World competition, often.
Leave a Comment